Three major financial institutions have launched a mechanism to deploy pension capital toward high-potential UK science and technology ventures, addressing a persistent shortage of growth funding for companies transitioning from laboratory to market. Scottish Widows, Aberdeen Investments and IP Group unveiled their initial commitments through the CG Scottish Widows Growth LTAF, positioning workplace pension savings as a source of patient institutional capital for British innovators.

The initiative represents an early move among UK pension schemes to actively direct member capital into domestic venture growth, linking long-term savings with businesses demonstrating both scientific leadership and commercial potential. Aberdeen Investments manages the growth component for Scottish Widows, with IP Group overseeing a dedicated UK venture portfolio within the broader fund structure.

Four companies are receiving initial backing through this arrangement:

  • Oxford Quantum Circuits, developing quantum computing systems ready for commercial deployment
  • Quantum Motion, engineering silicon-based quantum computers intended for widespread adoption
  • Nyobolt, advancing ultra-fast-charging battery technology for high-performance energy storage applications
  • Genomics Limited, leveraging artificial intelligence and machine learning alongside large-scale genetic datasets to reshape drug discovery and preventative medicine

The partnership model is structured to expand progressively, potentially increasing the volume of long-term pension capital flowing into high-growth British enterprises as part of the Fund's wider private markets strategy. The arrangement aims simultaneously to strengthen retirement outcomes for pension members and to resolve a significant constraint limiting UK innovation: the scarcity of meaningful follow-on capital for companies prepared to scale operations.

We believe pension savers should be able to benefit from the growth and innovation taking place across the UK. Our proposition helps connect our workplace pension customers' long-term savings with some of Britain's most innovative, high-growth companies, giving them access to investment opportunities that have traditionally been available mainly to institutional investors.

Peter Fitzgerald, Chief Investment Officer, Scottish Widows

The UK has no shortage of scientific excellence and does not lack entrepreneurship or talent to develop globally relevant ideas. What competitive companies have lacked is sufficient pools of patient domestic capital to help them expand and grow. This partnership turns intent into investment.

Nalaka De Silva, Head of Private Markets Solutions, Aberdeen Investments

Source: Tech.eu